VNDA insider filings
Vanda Pharmaceuticals Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-05. Screen VNDA transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 1 filing by 1 insider — 10,000 shares, $38,094 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 5,803 shares @ $3.80 ($22,076) by Duncan Charles Cliff, filed 2026-11-05.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Duncan Charles Cliff — Director | 1 | 3 legs · 10,000 sh · $38,094 | — | — |
Recent insider filings — Vanda Pharmaceuticals Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-05 | 4 | Duncan Charles Cliff — Director | Purchase (P): 750 @ $3.80 · Purchase (P): 3,447 @ $3.82 · Purchase (P): 5,803 @ $3.80 | EDGAR |
| 2026-06-08 | 4 | McGuire Daniel Patrick — SVP, GC and Secretary | Grant/award (A): 80,000 @ $0 | EDGAR |
| 2026-06-08 | 4 | Chrousos Phaedra — Director | Grant/award (A): 41,600 @ $0 | EDGAR |
| 2026-06-08 | 4 | Duncan Charles Cliff — Director | Grant/award (A): 41,600 @ $0 | EDGAR |
| 2026-06-08 | 4 | Ward Anne Sempowski — Director | Grant/award (A): 41,600 @ $0 | EDGAR |
| 2026-06-08 | 4 | Honore Tage — Director | Grant/award (A): 41,600 @ $0 | EDGAR |
| 2026-06-08 | 4 | Mitchell Stephen Ray — Director | Grant/award (A): 41,600 @ $0 | EDGAR |
| 2026-06-08 | 4 | DUGAN RICHARD W — Director | Grant/award (A): 41,600 @ $0 | EDGAR |
| 2026-05-20 | 4 | Mitchell Stephen Ray — Director | Gift (G): 25,836 @ $0 | EDGAR |
| 2026-04-24 | 4 | Duncan Charles Cliff — Director | Grant/award (A): 57,101 @ $0 | EDGAR |
| 2026-03-04 | 4 | Moran Kevin Patrick — SVP, CFO & Treasurer | Sale (S): 42,442 @ $8.27 | EDGAR |
| 2026-03-04 | 4 | Wijkstrom Joakim — SVP, Chief Marketing Officer | Sale (S): 30,800 @ $8.27 | EDGAR |
| 2026-03-04 | 4 | Williams Timothy — SVP & General Counsel | Sale (S): 42,434 @ $8.27 | EDGAR |
| 2026-03-04 | 4 | Birznieks Gunther — SVP, Business Development | Sale (S): 42,431 @ $8.27 | EDGAR |
| 2026-03-04 | 4 | Polymeropoulos Mihael Hristos — President and CEO, Director | Sale (S): 156,235 @ $8.17 | EDGAR |
| 2026-02-24 | 4 | Honore Tage — Director | Sale (S): 30,000 @ $8.03 | EDGAR |
| 2026-02-19 | 4 | Wijkstrom Joakim — SVP, Chief Marketing Officer | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2026-02-19 | 4 | Birznieks Gunther — SVP, Business Development | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2026-02-19 | 4 | Williams Timothy — SVP & General Counsel | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2026-02-19 | 4 | Moran Kevin Patrick — SVP, CFO & Treasurer | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2026-02-19 | 4 | Polymeropoulos Mihael Hristos — President and CEO, Director | Grant/award (A): 525,000 @ $0 | EDGAR |
| 2025-08-08 | 4 | Polymeropoulos Mihael Hristos — President and CEO, Director | Purchase (P): 10,000 @ $4.15 | EDGAR |
| 2025-06-16 | 4 | Mitchell Stephen Ray — Director | Sale (S): 7,000 @ $4.59 | EDGAR |
| 2025-06-09 | 4 | Mitchell Stephen Ray — Director | Grant/award (A): 59,225 @ $0 | EDGAR |
| 2025-06-09 | 4 | Chrousos Phaedra — Director | Grant/award (A): 59,225 @ $0 | EDGAR |
| 2025-06-09 | 4 | Honore Tage — Director | Grant/award (A): 59,225 @ $0 | EDGAR |
| 2025-06-09 | 4 | Ward Anne Sempowski — Director | Grant/award (A): 59,225 @ $0 | EDGAR |
| 2025-06-09 | 4 | DUGAN RICHARD W — Director | Grant/award (A): 59,225 @ $0 | EDGAR |
| 2025-05-21 | 4 | Polymeropoulos Mihael Hristos — President and CEO, Director | Purchase (P): 9,519 @ $4.40 · Purchase (P): 481 @ $4.39 | EDGAR |
| 2025-05-19 | 4 | Polymeropoulos Mihael Hristos — President and CEO, Director | Purchase (P): 20,000 @ $4.22 | EDGAR |
| 2025-03-06 | 4 | Polymeropoulos Mihael Hristos — President and CEO, Director | Purchase (P): 5,000 @ $5.02 · Purchase (P): 5,000 @ $5.01 | EDGAR |
| 2025-03-05 | 4 | Polymeropoulos Mihael Hristos — President and CEO, Director | Purchase (P): 5,000 @ $5.01 · Purchase (P): 5,000 @ $5.03 | EDGAR |
| 2025-03-04 | 4 | Wijkstrom Joakim — SVP, Chief Marketing Officer | Tax withholding (F): 15,520 @ $4.76 | EDGAR |
| 2025-03-04 | 4 | Birznieks Gunther — SVP, Business Development | Tax withholding (F): 26,941 @ $4.76 | EDGAR |
| 2025-03-04 | 4 | Polymeropoulos Mihael Hristos — President and CEO, Director | Tax withholding (F): 95,999 @ $4.76 · Purchase (P): 10,000 @ $4.71 | EDGAR |
| 2025-03-04 | 4 | Moran Kevin Patrick — SVP, CFO & Treasurer | Tax withholding (F): 26,941 @ $4.76 | EDGAR |
| 2025-03-04 | 4 | Williams Timothy — SVP & General Counsel | Tax withholding (F): 26,941 @ $4.76 | EDGAR |
| 2025-02-28 | 4 | Polymeropoulos Mihael Hristos — President and CEO, Director | Purchase (P): 10,000 @ $4.76 | EDGAR |
| 2025-02-27 | 4 | Polymeropoulos Mihael Hristos — President and CEO, Director | Purchase (P): 10,000 @ $4.76 | EDGAR |
| 2025-02-26 | 4 | Polymeropoulos Mihael Hristos — President and CEO, Director | Purchase (P): 5,000 @ $4.75 · Purchase (P): 5,000 @ $4.78 | EDGAR |
| 2025-02-25 | 4 | Polymeropoulos Mihael Hristos — President and CEO, Director | Purchase (P): 10,000 @ $4.46 | EDGAR |
| 2025-02-24 | 4 | Moran Kevin Patrick — SVP, CFO & Treasurer | Purchase (P): 2,000 @ $4.39 | EDGAR |
| 2025-02-20 | 4 | Wijkstrom Joakim — SVP, Chief Marketing Officer | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2025-02-20 | 4 | Polymeropoulos Mihael Hristos — President and CEO, Director | Grant/award (A): 450,000 @ $0 | EDGAR |
| 2025-02-20 | 4 | Moran Kevin Patrick — SVP, CFO & Treasurer | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2025-02-20 | 4 | Birznieks Gunther — SVP, Business Development | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2025-02-20 | 4 | Williams Timothy — SVP & General Counsel | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2024-11-18 | 4 | Mitchell Stephen Ray — Director | Sale (S): 5,000 @ $5.17 | EDGAR |
| 2024-07-29 | 4 | Moran Kevin Patrick — SVP, CFO & Treasurer | Sale (S): 2,251 @ $5.92 | EDGAR |
| 2024-05-24 | 4 | Chrousos Phaedra — Director | Grant/award (A): 21,887 @ $0 · Grant/award (A): 40,202 (derivative) @ $0 | EDGAR |
Recent 8-K events — Vanda Pharmaceuticals Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2026-10-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-10 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-02-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=VNDA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs